Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21306238 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
Condition: Advanced Neuroendocrine Tumors of Pancreatic Origin
Interventions: Drug: Everolimus;   Drug: Everolimus Placebo

Study has passed its completion date and status has not been verified in more than two years.